DARCY COOK: Open Payments
NPI 1629699251 · EMMETT, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 36 payments from 17 companies in 2025. Trend: 2023 $282 · 2024 $1,122 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $187 |
| AstraZeneca Pharmaceuticals LP | 3 | $158 |
| Antares Pharma, Inc. | 3 | $58 |
| Boston Scientific Corporation | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Lilly USA, LLC | 2 | $46 |
| Novo Nordisk Inc | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Exact Sciences Corporation | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: UBRELVY, FARXIGA, XYOSTED, REXULTI, AIRSUPRA, WATCHMAN FLX, Ozempic, TRELEGY ELLIPTA.
Industry payments across ID — which companies pay providers there.
